University of Birmingham Belimumab in kidney transplantation

Shaun M. Flint, Nicholas Torpey FRCP, Paul A. Lyons,Don N. Shanahan,Adele Gibson, E. ChristopherJ., Watson, Ann-Marie O'Sullivan MRes, Joseph A. Chadwick, Katie E. Foster,Rachel B. Jones, Luke R. Devey MRCSEd, Lars-Peter Erwig, Caroline O. Savage FMedSci, Kenneth G. C. Smith, FMedSci,Robert B. Henderson,Menna R. Clatworthy

semanticscholar

引用 0|浏览0

暂无评分

摘要

Citation for published version (Harvard): Banham, GD, Flint, SM, Torpey, N, Lyons, PA, Shanahan, DN, Gibson, A, Watson, CJE, O'Sullivan, A-M, Chadwick, JA, Foster, KE, Jones, RB, Devey, LR, Richards, A, Erwig, L-P, Savage, CO, Smith, KGC, Henderson, RB & Clatworthy, MR 2018, 'Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial', The Lancet, vol. 391, no. 10140, pp. 2619-2630. https://doi.org/10.1016/S0140-6736(18)30984-X

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要